液基细胞学联合肿瘤免疫志物检测对恶性腹水的诊断价值探讨

Study of value of LPT combined with tumor marker in the diagnosis of malignant ascites

目的研究液基细胞学检查联合肿瘤免疫标志物检测在恶性腹水中的诊断价值。方法检测40例经利普液基细胞学(LPT)诊断为恶性腹水标本(腺癌)与40例良性腹水标本的肿瘤标志物,观察两种标本的肿瘤标志物水平。结果液基细胞学诊断为癌症的肿瘤标志物水平高于良性标本的标志物水平。结论液基细胞学检测联合肿瘤标志物检测可提高恶性腹水的检出率和确诊率。

Objective To investigate the diagnostic value of LPT combined with tumor marker in the diagnosis of malignant ascites.Methods The levels of tumor marker in forty specimen of malignant ascites adenocarcinoma diagnosed by LPT and forty specimen of nonmalignant ascites were observed.Result The level of tumor marker was higher in malignant ascites diagnosed by LPT than in the nonmalignant ascites.Conclusion LPT combined with tumor marker in the diagnosis of malignant ascites could improve the detection rate and accuracy rate.